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Heparan sulfate (HS) 3-O-sulfotransferase isoform-2 (3-OST-2), which belongs to a family of enzymes capable of generating herpes simplex
virus type-1 (HSV-1) entry and spread receptors, is predominantly expressed in human brain. Despite its unique expression pattern, the ability of
3-OST-2 to mediate HSV-1 entry and cell-to-cell fusion is not known. Our results demonstrate that expression of 3-OST-2 can render Chinese
hamster ovary K1 (CHO-K1) cells susceptible to entry of wild-type and mutant strains of HSV-1. Evidence for generation of gD receptors by 3-
OST-2 were suggested by gD-mediated interference assay and the ability of 3-OST-2-expressing CHO-K1 cells to preferentially bind HSV-1 gD,
which could be reversed by prior treatment of cells with HS lyases (heparinases II/III). In addition, 3-OST-2-expressing CHO-K1 cells acquired
the ability to fuse with cells-expressing HSV-1 glycoproteins, a phenomenon that mimics a way of viral spread in vivo. Demonstrating specificity,
the cell fusion was inhibited by soluble 3-O-sulfated forms of HS, but not unmodified HS. Taken together, our results raise the possibility of a role
of 3-OST-2 in the spread of HSV-1 infection in the brain.
D 2005 Elsevier Inc. All rights reserved.Keywords: HSV-1; Entry; Heparan sulfate; Membrane fusionIntroduction
Herpes simplex virus-1 (HSV-1) is associated with multiple
human diseases ranging from cold sores or fever blisters on
mucosal layers of the skin to meningitis and encephalitis in the
brain (Eisenstein et al., 2004; Whitley and Roizman, 2001).
While the molecular details of the viral spread from skin to
central nervous system are yet to be fully understood, it is
likely that HSV-1 entry receptors play a key role in the spread
process. In this regard, expression in the brain of heparan
sulfate (HS) 3-O-sulfotransferase isoform-2 (3-OST-2), which
is a member of the 3-O-sulfotransferase (3-OST) family of
enzymes that can generate entry receptors for HSV-1, raises
genuine curiosity about its ability to mediate HSV-1 infection
(Shukla et al., 1999; Shukla and Spear, 2001; Shworak et al.,
1999).0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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1 Equal contribution.The virus, HSV-1, is a member of the herpesvirus family and
alphaherpesvirus subfamily. According to the current model of
HSV-1 entry, HS plays an important role in the attachment of
the viral glycoproteins gC or gB to the target cell surface
(Herold et al., 1991; Shieh et al., 1992; WuDunn and Spear,
1989). After attachment, fusion between the viral envelope and
the target cell membrane is required for entry into cells. It is
triggered by the binding of viral glycoprotein gD to one of its
cell surface receptors in association with three other glycopro-
teins: gB, gL, and gH (Spear and Longnecker, 2003; Yoon et al.,
2003). The gD receptors include nectin-1 and nectin-2, both of
which are members of the immunoglobulin superfamily
(Cocchi et al., 2000; Geraghty et al., 1998; Warner et al.,
1998), HVEM, which is a member of the TNF-receptor family
(Montgomery et al., 1996), and the modifications in HS
triggered by some selective members of the 3-O-sulfotrans-
ferases (3-OSTs) family giving rise to the 3-O-sulfated HS (3-
OS HS) gD receptor family (Shukla et al., 1999; Xia et al.,
2002; Xu et al., 2005).
Physiologically, 3-OS HS is generated after multiple
rounds of enzymatic modifications (including sulfations and6) 452 – 459
www.e
Fig. 1. Viral entry is dependent on the expression of 3-OST-2. (A) Entry of
HSV-1(KOS). Chinese hamster ovarian (CHO-K1) cells were transfected with
3-OST-2, 3-OST-3-expressing plasmids or empty vector pCDNA3.1(+), as
indicated. About 16 h after transfection, h-galactosidase-expressing HSV-1
KOS gL86 virus was added to the cells at the dosages indicated and incubated
for 6 h. Viral entry was measured (as optical density, OD) using o-nitrophenyl-
h-d-galactopyranoside (ONPG) substrate. (B) Entry of HSV-1 (Rid1). CHO-
K1 cells were transected with 3-OST-2, nectin-1-expressing plasmids or empty
vector pCDNA3.1 and infected with recombinant h-galactosidase-expressing
Rid1tk12 virus at the dosages indicated. Viral entry was measured as described
above.
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normally composed of repeating disaccharide units (d-
glucuronic or iduronic acid and N-acetylglucosamine)
(reviewed by Lindahl et al., 1998; Rosenberg et al., 1997).
The 3-O sulfation of glucosamine residues, which is the
known function of 3-OSTs, is the last step in HS maturation
process (Esko and Selleck, 2002; Rosenberg et al., 1997).
Thus far seven different isoforms of 3-OST have been
identified (3-OST-1, -2, -3A, -3B, -4, -5, and -6). These
isoforms are able to recognize some specific monosaccharide
sequences around the modification sites (Liu et al., 1999;
Shworak et al., 1999; Xia et al., 2002; Xu et al., 2005).
Despite the strong homology between the isoforms, 3-OS HS
generated by individual enzymes appear to carry distinct
‘‘signatures’’ of the modifying enzymes. This is evident from
the emerging data that modification by 3-OST-1 fails to
generate HSV-1 entry receptor but strongly enhances anti-
thrombin (AT) binding to HS, whereas 3-OST-3A and -3B
isoforms, which are almost identical in structure and substrate
specificities, do just the reverse (Liu and Rosenberg, 2002;
Shukla et al., 1999; Shukla and Spear, 2001). In contrast, 3-
OST-5 and 3-OST-6 each appear to perform both functions,
but HSV-1 entry, like 3-OST-3, is limited to only the wild-
type strains (Shukla et al., 1999; Tiwari et al., 2004; Xia et al.,
2002; Xu et al., 2005). Interestingly, the ability of 3-OST-2
and 3-OST-4 isoforms to mediate HSV-1 entry and any unique
features of 3-OS HS generated by the two enzymes have not
been demonstrated.
The present study aims to identify a role for 3-OS HS
modified by the 3-OST-2 isoform in HSV-1 entry and
spread and at the same time look for evidence for any
characteristic differences in HS generated by 3-OST-2. The
results presented below demonstrate the ability of the
enzyme to generate receptors for both wild-types and some
mutant forms of HSV-1. The mutants, commonly known as
Rid, carry a common point mutation at position 27 of gD
(Dean et al., 1994; Montgomery et al., 1996). The ability
to mediate entry of mutant virions with the Rid forms of
gD appears to be a unique feature of 3-OS HS generated
by 3-OST-2.
Results
Effect of 3-OST-2 expression on viral entry
Wild type Chinese hamster ovarian (CHO-K1) cells lack a
functional HSV-1 gD receptor and are thus resistant to HSV-1
entry (Shieh et al., 1992). However, they can be made
susceptible to entry through the transient transfection of
plasmids expressing gD receptors (Montgomery et al., 1996).
Thus, in order to determine the ability of 3-OST-2 to mediate
HSV-1 entry, CHO-K1 cells were transiently transfected with
3-OST-2 expression and control plasmids. Reporter virus
entry assays were performed to determine whether the
expression of 3-OST-2 rendered CHO-K1 cells susceptible
to entry of wild-type and a mutant, Rid1, forms of HSV-1
(Dean et al., 1994). The latter has a point mutation at position27 (Q27P) of gD which prevents its entry via some receptors
including HVEM and 3-OS HS generated by 3-OST-3 (Dean
et al., 1994; Montgomery et al., 1996; Shukla et al., 1999). h-
galactosidase-expressing recombinant HSV-1 (KOS) gL-86
and HSV-1Rid1tk12 respectively represented the wild-type
and the mutant strains of HSV-1. In each assay, we compared
the results with 3-OST-2 with that of a positive control: 3-
OST-3 for HSV-1 (KOS) and nectin-1 for HSV-1 (Rid1). An
empty vector, pCDNA3.1 (+) (Invitrogen), was used as the
negative control. Clearly, as shown (Fig. 1), there was a
significant increase in viral entry relative to those cells that
were transfected with empty vector alone. For HSV-1 KOS
(Fig. 1A), the response seen with 3-OST-2 expressing cells
was comparable to that of the 3-OST-3 expressing cells, and,
similarly, in entry of Rid1tk12 into 3-OST-2 cells and nectin-
1 cells infected with the same virions (Fig. 1B). Thus, it
appears that both HSV-1 (KOS) and Rid1 virions are able to
use the 3-OS HS generated by 3-OST-2 as a receptor for
entry into target cells. More specifically, the results also
Fig. 2. Entry of various HSV-1 wild type and mutant strains in 3-OST-2
expressing cells. Entry of HSV-1 wild type strains (KOS, Patton, HFEM, 17)
and mutant strains (Rid1, Rid2, ANG). Chinese hamster ovarian (CHO-K1) and
h-galactosidase-expressing IEh8 cells were transfected with 3-OST-2 expres-
sing plasmids or empty vector pCDNA3.1 (+), as indicated. Cells were also
transfected with 3-OST-3 or nectin-1 expressing plasmids to serve as a positive
control (data not shown). Viral entry assay was performed as described in Fig.
1. Each bar represents entry at a viral concentration of 15 pfu per cell for cells
expressing 3-OST-2 and those transfected with empty vector.
Fig. 3. Co-expression of gD with 3-OST-2 renders resistance to HSV-1 entry
(A) Effects of HSV-1 glycoprotein gD when coexpressed with 3-OST-2 on
entry of HSV-1(KOS). CHO-K1 cells were co-transfected with 3-OST-2
expression plasmid and gD expression plasmid or pCDNA3.1 (+) as indicated
The cells were then infected with HSV-1 KOS gL86 at the doses indicated
After 6 h, o-nitrophenyl-h-d-galactopyranoside (ONPG) substrate was added
and viral entry was measured spectrophotometrically (OD410). (B) Effects o
HSV-1 Rid1 gD on HSV-1(KOS)Rid1 entry when coexpressed with either 3
OST-2 or nectin-1. CHO-K1 cells were co-transfected with 3-OST-2 expression
plasmid and Rid1 gD expression plasmid or pCDNA3.1 (+) as indicated and
infected with HSV-1 Rid 1. Viral entry was measured as described in panel A
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the mutant Rid1 form) could interact with the 3-OS HS
generated by 3-OST-2, which was verified through further
experiments.
After testing entry with HSV-1 (KOS) and Rid1 alone, we
decided to test the susceptibility of 3-OST-2 expressing cells to
a variety of HSV-1 wild type and mutant strains. Since none of
these new strains tested have h-galactosidase activity, IEh8
cells were used because this cell line is able to express h-
galactosidase upon HSV-1 entry (Montgomery et al., 1996).
Fig. 2 shows that each wild type strain (KOS, Patton, HFEM,
17) and each mutant strain (Rid2 and ANG) were able to use 3-
OS HS generated by 3-OST-2 as an entry receptor. The mutant
strains used have a common point mutation at position 27 in
gD (Montgomery et al., 1996).
gD-mediated interference assay with 3-OST-2 expressing cells
In order to generate evidence that the 3-OS HS generated by
3-OST-2 can also interact with gD, a gD-mediated interference
assay was performed. It is based on the observation that cells
co-expressing gD and one of its receptors become resistant to
HSV-1 entry due to sequestration of the entry receptor by
cellular gD (Geraghty et al., 2000; Shukla et al., 1999). Since
the process of interference is dependent on the relative ratio of
gD and the receptor, one effective way of controlling this in
vitro, is by co-transfecting cells with gD to receptor plasmids
ratio of 4:1 (Geraghty et al., 2000). Thus, using the same
ratio, cells were transfected with gD and 3-OST-2 expression
constructs, and changes in viral entry were observed
compared to the control cells transfected with 3-OST-2 and
the empty vector pcDNA3.1 (+). As shown in Fig. 3, for 3-
OST-2 cells co-expressing gD (wild-type or Rid1) there was asignificant reduction in viral entry when infected with either
HSV-1 KOS (Fig. 3A) or Rid1 (Fig. 3B) compared to those
that were not expressing the glycoproteins. For Rid1 (Fig.
3B), the response seen with 3-OST-2 in either case was very
similar to that seen with nectin-1 used as a positive control.
Thus, it can be assumed then that the reduction in viral entry
is due to the interaction of both forms of gD with 3-OS HS
generated by 3-OST-2.
Cell ELISA with soluble gD:Fc
To generate more direct evidence for the generation of gD
receptors by the action of 3-OST-2 enzyme on HS, a
previously defined soluble gD-cell binding assay was used
(Shukla et al., 1999). This assay is based on the principle that
a recombinant soluble form of HSV-1 gD fused with the Fc
portion of rabbit IgG (gD:Fc) can preferentially bind to cells
expressing 3-OS HS on their surfaces. As a way to
demonstrate the involvement of 3-OS HS as the gD receptor,.
.
.
,
f
-
.
Fig. 4. Enzymatic removal of 3-OST-2 modified HS from cells also removes
gD-binding receptors. A soluble recombinant form of HSV-1 gD (gD:Fc) was
allowed to bind cells expressing the 3-OST isoforms as indicated. The cells
were either treated with a mixture of heparinase II/III (treated) or mock treated
(untreated). Binding of gd:Fc was detected by use of a secondary antibody
against rabbit IgG:Fc and a horseradish peroxidase detection system
(Amersham). The values shown represent the amount of reaction product
detected spectrophotometrically (OD at 650 nm).
Fig. 5. 3-OST-2-expressing CHO-K1 cells gain the ability to fuse with cells co-
expressing HSV-1 glycoproteins gB, gD, gH and gL. The target cells were
transfected with plasmids expressing 3-OST-1, 3-OST-2, or 3-OST-3 (as
indicated) and luciferase reporter gene. The effector cells were transfected with
HSV-1 glycoproteins gB, gD, gH and gL, and T7 RNA polymerase. A
luciferase reporter assay was performed 24 h after the two cell populations were
mixed together. Cell fusion was measured in relative luciferase units (RLUs). 3-
OST-3 and 3-OST-1 were used as the positive and negative controls
respectively. (A) Expression of 3-OST-2 results in the fusion of CHO-K1 cells
with glycoprotein-expressing cells as measured by a reporter assay. (B)
Multinucleated cells or polykaryocytes were observed with cells expressing 3-
OST-2. CHO-K1 cells were transfected with plasmids expressing 3-OST
cDNAs as indicated and mixed with the effector cells and stained with gH and
gL monoclonal antibodies followed by detection with a biotinylated secondary
anti-mouse antibody, streptavidin conjugated with h-galactosidase and X-gal at
72 h post-mixing.
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treatment of cells with heparin lyases (heparinases) (Shukla et
al., 1999; Yabe et al., 2001). For this experiment, CHO-K1
cells were transiently transfected with 3-OST-2, 3-OST-3, or
nectin-1 and each divided into two groups. While one group
was treated with a mixture of heparinase II and III, the other
was mock treated with the buffer alone for the same amount
of time. If gD does bind to 3-OS HS generated by 3-OST-2
then we would expect to see a reduction in gD binding to the
cell surface of the heparinase-treated cells due to loss of 3-OS
HS by heparinase action. As shown in Fig. 4, there was a
significantly higher amount of gD:Fc bound to mock-treated
cells compared to those cells that were treated with
heparinase-II and -III. The use of nectin-1 in this experiment
shows the specificity of this assay for HS based receptors
since the binding of gD to nectin-1-expressing cells was not
significantly compromised by heparinase treatment. Thus,
based on this and the results from the gD-mediated
interference assay, it is very likely that expression of 3-
OST-2 in CHO-K1 cells results in generation of gD receptors
for HSV-1.
Effect of 3-OST-2 expression on viral induced cell fusion
After establishing the ability of 3-OST-2 in HSV-1 entry, we
next examined whether the receptor generated by this enzyme
could also facilitate cell-to-cell fusion. Once again CHO-K1
cells were used since due to the absence of a gD receptor,
CHO-K1 cells are resistant not only to HSV-1 entry, but virus-
induced cell fusion as well (Pertel et al., 2001; Shieh et al.,
1992). A standard luciferase reporter gene assay was performed
to quantify the induced cell fusion between 3-OS HS cells
modified by 3-OST-1, 3-OST-2, or 3-OST-3 and HSV-1
glycoproteins (Pertel et al., 2001). The ‘‘effector’’ CHO-K1
cells were transiently transfected with each of four glycoprotein
plasmids: pPEP98 (gB), pPEP99 (gD) pPEP100 (gH), andpPEP101 (gL), as well as, the plasmid pT7EMCLuc that
expresses a luciferase reporter gene. The ‘‘target’’ cells were
transfected with a 3-OST plasmid expressing 3-OST-1, 3-OST-
2, or 3-OST-3 and the plasmid pCAGT7, which expresses T7
RNA polymerase to induce expression of the luciferase gene.
For a negative control, cells were transfected with T7 RNA
polymerase and 3-OST-1 because 3-OS HS modified by this
isoform has been shown not to interact with HSV-1 (Shukla et
al., 1999; Tiwari et al., 2004; Xu et al., 2005). The cells
expressing 3-OST-3 and T7 RNA polymerase served as a
positive control. Fig. 5A shows a very similar high amount of
fusion occurring in both 3-OST-2 and 3-OST-3 expressing
cells. Clearly, the 3-OS HS generated by 3-OST-2 is capable of
mediating cell fusion as well.
Basically to verify the results obtained by the luciferase
assay we decided to look at polykaryocyte formation by
mixing of 3-OST-2-expressing target cells with the effector
cells. This phenomenon mimics multinucleated cell (polykar-
yocyte) formation during an actual HSV-1 infection whereby
infected cells fuse with uninfected neighboring cells allowing
the spread of the virions to the neighboring cells. Since it is
possible for polykaryocytes to spontaneously form in some
instances, a blue plaque assay was performed to show the
Fig. 6. 3-OS HS is likely the mediator of the cell fusion. (A) Degradation of HS
by the addition of heparinase-II/III reduces cell fusion. Cell expressing the fou
viral glycoproteins (gB, gD, gH and gL) were treated with heparinase-II/II
(black bar) or left untreated (white bar) prior to mixing with cells expressing
either 3-OST-2, 3-OST-3 or nectin-1. Luciferase activity was measured 24 h
after co-cultivation in relative luciferase units (RLUs) using a Sirius
luminometer. (B) Soluble 3-O-sulfated heparan sulfate (3-OS-HS), modified
by 3-OST-3 and 3-OST-5 inhibits cell fusion. The effector cells were treated
with soluble 3-OS HS generated by the isoform indicated above bars. The
treatments were performed prior to mixing with the target cells expressing 3
OST-2 or 3-OST-3 plasmids. Luciferase activity was measured in RLUs.
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proteins. A monoclonal antibody for gH and gL was used to
identify HSV-1 viral glycoprotein expression. Our results (Fig.
5B) show formation of polykaryocytes in the cell populations
expressing 3-OST-2, which were similar in size to those cells
expressing 3-OST-3. Clearly, virtually none were seen in the 3-
OST-1 expressing cells. The background seen in each well is
due to effector cells expressing gH and gL that did not fuse
with target cells. Transfection is not 100% efficient so it is not
uncommon for glycoprotein cells to fail to come into contact
with target cells expressing HSV-1 viral receptors. However,
clearly a difference can be seen between plaques and the
individual cells that have been stained with h-galactosidase. A
similar polykaryocyte formation study was done, except the
cells were stained with Giemsa, instead of h-galactosidase.
Similar results were seen with the 3-OST-2 and 3-OST-3 cells
showing large polykaryocytes similar in size, and the 3-OST-1
expressing cells with virtually no polykaryocyte formation
(data not shown). These results reinforce our finding that cells
expressing 3-OST-2 allow cell fusion to occur, and thus
potentially could facilitate spread of HSV-1 in an actual
infection.
Next, to gain evidence that cell surface expression of 3-OS
HS, and not the enzyme itself, was responsible for the
induction of the cell fusion, the effect of enzymatic removal
of 3-OS HS on cell fusion by treatment with a mixture of
heparinase II and III was studied. These enzymes selectively
degrade HS chains by cleaving them. For this experiment, 3-
OST-2 and 3-OST-3-expressing CHO-K1 cells (as a positive
control) were separated into two distinct pools, one treated with
heparinase-II/III and the other untreated and mixed with the
effector cells expressing HSV-1 glycoproteins. Nectin-1
expressing cells were used as a control to show that the effect
of heparinase treatment was specific to 3-OST-2 (3-OST-3)
cells. As seen in Fig. 6A, untreated cells expressing 3-OST-2
and 3-OST-3 show fusion occurring, with 3-OST-2 cells
showing a slight increase in luciferase activity, while the cells
treated with heparinase-II/III showed about a 90% reduction in
fusion. The results indicate that it is the 3-OS HS on the cell
surface of the target cells modified by 3-OST-2 that HSV-1 is
binding with to induce fusion and not the enzyme itself or any
other receptor.
To verify further that 3-OS HS is the mediator of the fusion,
a competition assay was performed using soluble forms of 3-
OS HS generated in vitro by purified 3-OST-1, 3-OST-3, or 3-
OST-5 enzymes (Tiwari et al., 2004). Approximately 1.0 Ag/ml
of the soluble HS of each kind were added to the glycoproteins
expressing effector cells, prior to mixing with 3-OST-2-
expressing target cells. The glycoprotein expressing effector
cells with mock HS treatment (buffer alone) was considered a
control. We hypothesized that 3-OST3B and 3-OST-5 gener-
ated 3-OS HS should competitively inhibit fusion whereas 3-
OST-1 generated should not, as it fails to bind gD (Shukla et
al., 1999; Tiwari et al., 2004). Results shown in Fig. 6B
confirm our hypothesis. This figure shows a significant
reduction in fusion in the cell populations that received either
soluble 3-OS HS generated by 3-OST-3 or 3-OST-5 comparedr
I
-to the cells that received the non-gD binding soluble 3-OS HS
generated by 3-OST-1. These results indicate that 3-OS HS
generated by 3-OST isoforms capable of mediating entry can
specifically block the fusion induced by cells-expressing 3-
OST-2. It is worth mentioning here that Browne et al. (2001)
have previously found that significantly higher concentration
(at least 50 Ag/ml) of heparin was required to effectively block
the fusion of COS 7 cells expressing HSV-1 glycoproteins with
Vero cells. Some possible explanations for our result include
the use of a different cell line (CHO-K1), use of a specific gD
receptor (3-OS HS) as opposed to an unknown combination of
gD receptors in the cell lines used by them, and use of
specifically modified soluble HS (instead of heparin).
Discussion
Among the major achievements of our study are the
demonstration of the ability of 3-OST-2 isoform to generate
HSV-1 entry and also cell-to-cell fusion receptors, both of
which could play important roles in the spread of the viral
infection in vivo. Similarly, the finding that Rid1 and related
mutant virions (Rid2 and ANG) can use 3-OS HS generated by
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potentially unique structural features of the final products
generated by 3-OST-2 compared to the other members of the
family. This finding is also a testament to the theory that
different 3-OST isoforms are capable of generating very
specific and somewhat unique structures within HS chains
generating protein binding sites for regulating many important
cellular processes (Rosenberg et al., 1997). Clearly, HS is
already known for its ability to activate certain ligands
including, anti-thrombin, chemokines, cell adhesion molecules,
and a variety of growth factors (Lindahl et al., 1998; Rosenberg
et al., 1997).
It is very interesting that 3-OST-2 isoform is predominantly
expressed in the brain (Xu et al., 2005; Shworak et al., 1999)
raising curiosity about its normal biological functions and also
its ability to mediate HSV-1 entry. Obviously, the enzyme plays
some important regulatory functions since loss of its expression
is associated with many types of cancers (Miyamoto et al.,
2003). Although our study does not address any issues related
with its normal biological functions, we do, however, provide
some clues about the final products generated by this enzyme.
It is likely that 3-OS HS generated by this enzyme contains a
disaccharide-IdoA2S-GlcNH23S-(or-IdoA2S-GlcNH23S6S-),
which is required for HSV-1 wild-type gD binding activity
(Shukla et al., 1999; Xia et al., 2002; Xu et al., 2005). Other
disaccharide products generated by this enzyme could very
well be unique to it, since no other 3-OST isoform is currently
known to generate receptors for the Rid1 form of gD. Our
findings will, hopefully, guide future efforts to carefully
identify the final products generated by this enzyme.
Regarding the ability of 3-OST-2 to mediate HSV-1 entry, it
is indeed a serious matter that HSV-1 is capable of spreading to
and infecting human brain causing deadly diseases like
encephalitis and meningitis (Eisenstein et al., 2004; Whitley
and Kimberlin, 2005). Although the in vivo spread of the virus
infection is a complicated process determined by multiple
host–pathogen factors, the role of entry receptors in this
process cannot be ruled out. In fact, we believe it is likely that
the entry receptors play a crucial role in the spread of the
infectious virions. Among the well-characterized gD receptors,
nectin-1, appears to be the prime candidate for mediating viral
spread to and within the brain (Simpson et al., 2005; Shukla et
al., 1999). Our findings present a new possibility of an
additional receptor playing a role in HSV-1 infection of the
brain. Quite interestingly, this finding could help resolve any
receptor related issues associated with the differences seen in
the spread patterns (or tissue tropism) of HSV-1 and HSV-2 in
the brain tissue, especially since HSV-2 is frequently associated
with meningitis but not encephalitis in adults (Eisenstein et al.,
2004; Whitley and Roizman, 2001; Whitley and Kimberlin,
2005). If receptors have any role in this, it could not be
explained if nectin-1 were the only receptor in the brain since it
is a receptor for both HSV-1 and -2 (Geraghty et al., 1998).
Since like any other 3-OSTs, the receptor generated by 3-OST-
2 fails to mediate HSV-2 entry (data not shown), it is possible
that the existence of a HSV-1 specific receptor like the one
generated by 3-OST-2 in the brain could potentially providesome explanation for the inability of HSV-2 to cause
meningitis in the adult brain. Of course, it is premature to
make any such conclusions yet, but this study does however,
provide a good starting point to further understand the role of
the entry receptors, their age related expression patterns, and
other molecular determinants of the viral spread in the brain.
Materials and methods
Materials
Human 3-OST-2 and 3-OST-3-expressing plasmids were
received as a gift from Dr. Jian Liu (University of North
Carolina, Chapel Hill) (Shworak et al., 1999). The HSV-1
(KOS) glycoprotein expressing plasmids used were pPEP98
(gB), pPEP99 (gD), pPEP100 (gH), and pPEP101 (gL) (Pertel
and Spear, 1997). Other plasmids used include pMW13 (RID1
gD), pCAGT7 (T7 RNA polymerase), pT7EMCLuc (luciferase
gene) for the luciferase assay, and a control empty vector
pCDNA3.1 (+) from Invitrogen (Carlsbad, CA, USA). Hepar-
inase-II and -III were obtained from Sigma chemical company,
while the o-nitrophenyl-h-d-galactopyranoside (ONPG) rea-
gent was from ImmunoPure.
Cell culture and viruses
Wild type Chinese hamster ovarian-K1 (CHO-K1) cells and
IEh8 cells were provided by P.G. Spear (Northwestern
University). All CHO-K1 cells were grown in Ham’s F-12
medium (Gibco/BRL), Carlsbad, CA, USA) supplemented
with 10% fetal bovine serum (FBS) and penicillin and
streptomycin (Gibco/BRL). The h-galactasidase expressing
recombinant HSV-1 (KOS) gL86 and HSV-1 (KOS) Rid1tk12
viruses were provided by P.G. Spear (Northwestern Universi-
ty). The other HSV-1 wild type (Patton, HFEM,17) and mutant
strains (ANG and Rid2) were also provided by P.G. Spear
(Northwestern University).
HSV-1 viral entry assay
Standard entry assays were used as described previously
(Shukla et al., 1999). Briefly, CHO-K1 (or IEh8 cells) cells
were transferred to 6-well plates, grown to a subconfluent
level, and transfected with 1 Ag of 3-OST isoforms (3-OST-2,
3-OST-3), nectin-1, gD or pCDNA3.1 (+) using LipofectA-
MINE (Gibco/BRL). After about 16 h, the cells were
replated into 96-well dishes for infection with recombinant
viruses (or wild-type viruses of IEh8 cells). At 6-h post-
infection, h-galactasidase assay were performed using either
a soluble substrate o-nitrophenyl-h-d-galactopyranoside
(ONPG) or X-gal. For the soluble substrate, the enzymatic
activity was measured at 410 nm using a micro-plate reader
(Spectra Max 190, Molecular Devices, Sunnyvale, CA,
USA). For X-gal assay, the cells were fixed (2% formalde-
hyde and 0.2% glutaraldehyde) and permeabilized (2 mM
MgCl2, 0.01% deoxycholate, 0.02% nonidet NP-40 (Sigma)).
Finally, 1 ml of h-galactasidase reagent (1.0 mg/ml X-Gal in
C.D. O’Donnell et al. / Virology 346 (2006) 452–459458ferricyanide buffer) was added to each well and incubated at
37 -C for 90 min before the cells were examined using
bright field microscopy under the 20 objective (Zeiss,
Axiovert 100 M).
For the gD-mediated interference assay (Geraghty et al.,
2000; Shukla et al., 1999, 2000), cells were co-transfected
with 3-OST expression plasmid and either gD-expressing or
empty vector pCDNA3.1 (+) in a 1:1 ratio, with each plasmid
added at a final concentration of 1 Ag/Al. Thus, the total
amount of transfected DNA was kept constant. After
transfection, the cells were infected, and the infection was
quantitated by the ONPG assay as described above. The
enzymatic activity was measured at 410 nm using a micro-
plate reader (Spectra Max 190, Molecular Devices, Sunnyvale,
CA, USA).
Preparation of soluble forms of HS
Soluble HS from bovine kidney (ICN) was modified in
vitro either by purified 3-OST-1, 3-OST-3A, or 3-OST-5 (Dr.
Jian Liu, University of North Carolina, Chapel Hill) as
described elsewhere (Shukla et al., 1999; Tiwari et al.,
2004). The extent of 3-O-sulfation to HS was monitored by
determining the incorporation of [35S] sulfate into the
polysaccharide after in vitro modification by 3-OSTs. The
estimated numbers of 3-O-sulfate group per HS polysaccha-
ride chain was 1.1 sulfate /chain for 3-OST-1 modified HS; 1.3
sulfate/chain each for 3-OST-3A and 3-OST-5 modified HS.
The concentration of unlabeled HS was determined using
alcian blue dye (Bjornsson, 1998).
Cell fusion assays
A standard cell-to-cell fusion assay was used as described
previously (Pertel et al., 2001; Tiwari et al., 2004). Briefly,
CHO-K1 cells were grown in 6-well plates and grown to
a subconfluent level. The ‘‘target’’ cells were transfected
with plasmids expressing a 3-OST isoform and the
luciferase gene. The ‘‘effector’’ cells were transfected with
plasmids expressing HSV-1 glycoproteins gD, gB, gH, and
gL, and T7 RNA polymerase. In either case, the total
amount of transfected DNA was kept constant. After 16 h,
target and effector cells were mixed in a 1:1 ratio and
then replated in 24-well dishes. Luciferase activity was
measured 24 h later.
To demonstrate sensitivity to heparinase treatment target
cells were treated with a 1:1 mixture of heparinase-II/III for 2
h prior to mixing with the effector cells. Some cells were
mock treated with the buffer alone to serve as a control.
Luciferase activity was measured as described above. For
competition assay, 1 Ag/Al of HS generated in vitro by soluble
forms of 3-OST-1, 3-OST-3, and 3-OST-5 (Jian Liu,
University of North Carolina, Chapel Hill) were added to
the effector cells 2 h prior to mixing with the target cells.
Luciferase activity was measured 24 h later. For polykar-
yocyte study, a blue plaque assay was performed using a
monoclonal antibody for gH and gL detected by a biotiny-lated secondary anti-mouse antibody, streptavidin conjugated
with h-galactosidase and X-gal. The effector and target cells
were incubated for 72 h at 37 -C and 5% CO2 and observed
under the microscope for multinucleated giant cell (polykar-
yocyte) formation.
Cell ELISA
A cell ELISA protocol using a recombinant form of a
HSV-1 gD chimera with rabbit IgG Fc (gD1:Fc) was used as
described elsewhere (Geraghty et al., 2000; Shukla et al.,
1999). Briefly, the cells were transfected with identical
amounts of 3-OST-2, 3-OST-3, or nectin-1-expressing plas-
mids. After the monolayers have grown to confluence, soluble
gD1:Fc was added for 1 h. After multiple rounds of washing,
gD1:Fc binding was detected by biotinylated anti-rabbit IgG
(1:5,000 in PBS with 3% BSA) (Sigma) and a horseradish
peroxidase detection system (AMDEX streptavidin-conjugat-
ed horseradish peroxidase, from Amersham, Arlington
Heights, IL, USA) diluted 1:10,000. The slow kinetic form
of 3,3V, 5,5V-tetramethylbenzidine (Sigma) was used as the
substrate. The optical density was read at 650 nm using a
microplate reader (Spectra Max 190, Molecular Devices,
Sunnyvale, CA, USA).
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